Human Genome Sciences, Inc. Sciences Appoints Colin Goddard, Ph.D., to Its Board of Directors

December 14, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that Colin Goddard, Ph.D., former Chief Executive Officer of OSI Pharmaceuticals, has been appointed to the HGS Board of Directors.

Twitter
LinkedIn
Facebook
Email
Print

People